Skip to main content

Breast Augmentation

1
Pipeline Programs
3
Companies
9
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
6 programs
1
new texture shaped breast implantsPhase 41 trial
Anatomically shaped silicone gel-filled breast implantsN/A1 trial
Anatomically shaped, silicone-filled breast implants with low projection or extra-full projectionN/A1 trial
NatrelleN/A1 trial
New texture round breast implantsN/A1 trial
+1 more programs
Active Trials
NCT01853605Terminated3,811Est. Aug 2014
NCT01785069Terminated355Est. Nov 2015
NCT00689871Completed715Est. Aug 2011
+3 more trials
Galderma
GaldermaTX - Dallas
2 programs
Radiologial breast examinationN/A1 trial
Swedish Macrolane RegistryN/A1 trial
Active Trials
NCT01146275Completed6Est. Aug 2010
NCT01145235Completed1,300Est. Jan 2019
Erbe
ErbeGermany - Tübingen
1 program
Silicone ImplantN/A1 trial
Active Trials
NCT02302001Completed21Est. Jul 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbVienew texture shaped breast implants
ErbeSilicone Implant
AbbVieAnatomically shaped, silicone-filled breast implants with low projection or extra-full projection
AbbVieNew texture round breast implants
GaldermaSwedish Macrolane Registry
GaldermaRadiologial breast examination
AbbVieAnatomically shaped silicone gel-filled breast implants
AbbVieStyle 410 Silicone-Filled Breast Implants
AbbVieNatrelle

Clinical Trials (9)

Total enrollment: 7,186 patients across 9 trials

NCT01639755AbbVienew texture shaped breast implants

European New Texture Implant Clinical Experience With Shaped Breast Implants

Start: Jun 2012Est. completion: Oct 201719 patients
Phase 4Completed
NCT02302001ErbeSilicone Implant

Effects of Jet Hydro Dissection in Breast Augmentation Postoperative Pain

Start: Nov 2014Est. completion: Jul 201621 patients
N/ACompleted
NCT01785069AbbVieAnatomically shaped, silicone-filled breast implants with low projection or extra-full projection

Safety and Effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-filled X-Style and L-Style Breast Implants

Start: Dec 2012Est. completion: Nov 2015355 patients
N/ATerminated
NCT01639742AbbVieNew texture round breast implants

European New Texture Implant Clinical Experience With Round Breast Implants

Start: Jun 2012Est. completion: Oct 201718 patients
N/ACompleted
NCT01145235GaldermaSwedish Macrolane Registry

Swedish Macrolane Registry

Start: Apr 2010Est. completion: Jan 20191,300 patients
N/ACompleted
NCT01146275GaldermaRadiologial breast examination

A 7-year Follow up of All Subjects Incuded in Protocol 31GB0106

Start: Mar 2010Est. completion: Aug 20106 patients
N/ACompleted
NCT01853605AbbVieAnatomically shaped silicone gel-filled breast implants

NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study

Start: Apr 2003Est. completion: Aug 20143,811 patients
N/ATerminated
NCT00690339AbbVieStyle 410 Silicone-Filled Breast Implants

Safety and Effectiveness of Style 410 Silicone-Filled Breast Implant Study

Start: Feb 2001Est. completion: Dec 2012941 patients
N/ACompleted
NCT00689871AbbVieNatrelle

Safety and Effectiveness of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Start: Jan 1999Est. completion: Aug 2011715 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.